Fine-mapping of the 1p11.2 breast cancer susceptibility locus

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Horne, Hisani N ^a,b   Chung, Charles C ^a   Zhang, Han ^a   Yu, Kai ^a   Prokunina Olsson, Ludmila ^a   Michailidou, Kyriaki ^c   Bolla, Manjeet K ^c   Wang, Qin ^c   Dennis, Joe ^c   Hopper, John L ^d   Southey, Melissa C ^d   Schmidt, Marjanka K ^e   Broeks, Annegien ^e   Muir, Kenneth ^f,g   Lophatananon, Artitaya ^f   Fasching, Peter A ^h,i   Beckmann, Matthias W ^h   Fletcher, Olivia ^j   Johnson, Nichola ^j   Sawyer, Elinor J ^k   Tomlinson, Ian ^l   Burwinkel, Barbara ^m,n   Marme, Frederik ^m   Guénel, Pascal ^o,p   Truong, Thérèse ^o,p   Bojesen, Stig E ^q,r   Flyger, Henrik ^q   Benitez, Javier ^s,t   González Neira, Anna ^s   Anton Culver, Hoda ^u   Neuhausen, Susan L ^v   Brenner, Hermann ⁿ   Arndt, Volker ⁿ   Meindl, Alfons ^w   Schmutzler, Rita K ^x   Brauch, Hiltrud ^n,y,z   Hamann, Ute ⁿ   Nevanlinna, Heli ^aa   Khan, Sofia ^aa   Matsuo, Keitaro ^ab   Iwata, Hiroji ^ac   Dörk, Thilo ^ad   Bogdanova, Natalia V ^ad   Lindblom, Annika ^ae   Margolin, Sara ^ae   Mannermaa, Arto ^af,ag   Kosma, Veli Matti ^af,ag   Chenevix Trench, Georgia ^d,ah   Wu, Anna H ^ai   Ven Den Berg, David ^ai   Smeets, Ann ^aj   Zhao, Hui ^ak,al   Chang Claude, Jenny ^n,am   Rudolph, Anja ⁿ   Radice, Paolo ^an   Barile, Monica ^ao   Couch, Fergus J ^ap   Vachon, Celine ^ap   Giles, Graham G ^d,aq   Milne, Roger L ^d,aq   Haiman, Christopher A ^ai   Marchand, Loic Le ^ar   Goldberg, Mark S ^as,at   Teo, Soo H ^au,av   Taib, Nur A M ^av   Kristensen, Vessela ^aw,ax,ay   Borresen Dale, Anne Lise ^aw,ax   Zheng, Wei ^az   Shrubsole, Martha ^az   Winqvist, Robert ^ba,bb   Jukkola Vuorinen, Arja ^bc   Andrulis, Irene L ^bd,be   Knight, Julia A ^bd,be   Devilee, Peter ^bf   Seynaeve, Caroline ^bg   García Closas, Montserrat ^a,j   Czene, Kamila ^ae   Darabi, Hatef ^ae   Hollestelle, Antoinette ^bg   Martens, John W M ^bg   Li, Jingmei ^ae   Lu, Wei ^bh   Shu, Xiao Ou ^az   Cox, Angela ^bi   Cross, Simon S ^bi   Blot, William ^az,bj   Cai, Qiuyin ^az   Shah, Mitul ^c   Luccarini, Craig ^c   Baynes, Caroline ^c   Harrington, Patricia ^c   Kang, Daehee ^bk   Choi, Ji Yeob ^bk   Hartman, Mikael ^bl,bm   Chia, Kee Seng ^bl   Kabisch, Maria ⁿ   Torres, Diana ^n,bn   Jakubowska, Anna ^bo   Lubinski, Jan ^bo   Sangrajrang, Suleeporn ^bp   Brennan, Paul ^bq   Slager, Susan ^ap   Yannoukakos, Drakoulis ^br   Shen, Chen Yang ^bs,bt   Hou, Ming Feng ^bu   Swerdlow, Anthony ^j   Orr, Nick ^j   Simard, Jacques ^bv   Hall, Per ^ae   Pharoah, Paul D P ^c   Easton, Douglas F ^c   Chanock, Stephen J ^a   Dunning, Alison M ^c   Figueroa, Jonine D ^a,bw,bx   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^f UNIVERSITY OF WARWICK   (United Kingdom)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h UNIVERSITY HOSPITAL ERLANGEN   (Germany)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^k GUY S HOSPITAL   (United Kingdom)

^l UNIVERSITY OF OXFORD   (United Kingdom)

^m UNIVERSITY OF HEIDELBERG   (Germany)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^p UNIVERSITÉ PARIS SACLAY   (France)

^q GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^r UNIVERSITY OF COPENHAGEN   (Denmark)

^s Centro Nacional de Investigaciones Oncológicas   (Spain)

^t CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^w TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^x UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^y DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^z UNIVERSITY OF TÜBINGEN   (Germany)

^aa HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ab KYUSHU UNIVERSITY   (Japan)

^ac AICHI CANCER CENTER HOSPITAL   (Japan)

^ad HANNOVER MEDICAL SCHOOL   (Germany)

^ae KAROLINSKA INSTITUTE   (Sweden)

^af KUOPIO UNIVERSITY HOSPITAL   (Finland)

^ag UNIVERSITY OF EASTERN FINLAND   (Finland)

^ah QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^ai UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^aj UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^ak Vesalius Research Center   (Belgium)

^al UNIVERSITY OF LEUVEN   (Belgium)

^am UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^an NATIONAL CANCER INSTITUTE   (Italy)

^ao EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^ap MAYO CLINIC   (United States)

^aq CANCER EPIDEMIOLOGY CENTRE   (Australia)

^ar UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^as MCGILL UNIVERSITY   (Canada)

^at ROYAL VICTORIA HOSPITAL   (Canada)

^au CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^av UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^aw OSLO UNIVERSITY HOSPITAL   (Norway)

^ax UNIVERSITY OF OSLO   (Norway)

^ay OSLO UNIVERSITY HOSPITAL   (Norway)

^az VANDERBILT INGRAM CANCER CENTER   (United States)

^ba UNIVERSITY OF OULU   (Finland)

^bb Northern Finland Laboratory Centre NordLab Oulu   (Finland)

^bc OULU UNIVERSITY HOSPITAL   (Finland)

^bd MOUNT SINAI HOSPITAL   (Canada)

^be UNIVERSITY OF TORONTO   (Canada)

^bf LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^bg ERASMUS MC CANCER INSTITUTE   (Netherlands)

^bh Shanghai Center for Disease Prevention and Control   (China)

^bi UNIVERSITY OF SHEFFIELD   (United Kingdom)

^bj INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^bk Seoul National University   (South Korea)

^bl NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^bm NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^bn PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^bo POMERANIAN MEDICAL UNIVERSITY   (Poland)

^bp NATIONAL CANCER INSTITUTE   (Thailand)

^bq INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^br INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^bs CHINA MEDICAL UNIVERSITY   (Taiwan)

^bt INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^bu KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^bv Université Laval   (Canada)

^bw UNIVERSITY OF EDINBURGH   (United Kingdom)

^bx UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANCESTRY GROUP; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 1P; CONTROLLED STUDY; ENHANCER REGION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE DUPLICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INHERITANCE; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PROMOTER REGION; QUANTITATIVE TRAIT LOCUS; QUANTITATIVE TRAIT LOCUS MAPPING; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BIOLOGY; BREAST NEOPLASMS; CANCER GRADING; CASE CONTROL STUDY; CHROMOSOMAL MAPPING; CHROMOSOME 1; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HEALTH SURVEY; PROCEDURES;

ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; COMPUTATIONAL BIOLOGY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; NEOPLASM GRADING; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; QUANTITATIVE TRAIT LOCI; RISK ASSESSMENT;

EID: 84991088801     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0160316     Document Type: Article

References (43)

1. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nature genetics. 2009;41(5):585-90. Epub 2009/03/31. doi: 10.1038/ng.354 PMID: 19330027; PubMed Central PMCID: PMC2748125.
2. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptornegative breast cancer in the general population. Nature genetics. 2010;42(10):885-92. Epub 2010/09/21. doi: 10.1038/ng.669 PMID: 20852631; PubMed Central PMCID: PMC3130795.
3. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447(7148):1087-93. Epub 2007/05/29. doi: 10.1038/nature05887 PMID: 17529967; PubMed Central PMCID: PMC2714974.
4. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. Journal of the National Cancer Institute. 2011;103(5):425-35. doi: 10.1093/jnci/djq563 PMID: 21263130.
5. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nature genetics. 2012;44(3):312-8. doi: 10.1038/ng.1049 PMID: 22267197; PubMed Central PMCID: PMC3653403.
6. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nature genetics. 2011;43(12):1210-4. doi: 10.1038/ng.985 PMID: 22037553; PubMed Central PMCID: PMC3279120.
7. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nature genetics. 2007;39(7):870-4. doi: 10.1038/ng2075 PMID: 17529973; PubMed Central PMCID: PMC3493132.
8. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nature genetics. 2013;45(4):353-61, 61e1-2. Epub 2013/03/29. doi: 10.1038/ng.2563 PMID: 23535729.
9. Siddiq A, Couch FJ, Chen GK, Lindstrom S, Eccles D, Millikan RC, et al. A meta-analysis of genomewide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Human molecular genetics. 2012. Epub 2012/09/15. doi: 10.1093/hmg/dds381 PMID: 22976474.
10. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nature genetics. 2007;39(7):865-9. Epub 2007/05/29. doi: 10.1038/ng2064 PMID: 17529974.
11. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nature genetics. 2008;40(6):703-6. Epub 2008/04/29. doi: 10.1038/ng.131 PMID: 18438407.
12. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nature genetics. 2009;41(5):579-84. Epub 2009/03/31. ng.353 [pii] doi: 10.1038/ng.353 PMID: 19330030; PubMed Central PMCID: PMC2928646.
13. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nature genetics. 2009;41(3):324-8. Epub 2009/02/17. doi: 10.1038/ng.318 PMID: 19219042; PubMed Central PMCID: PMC2754845.
14. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nature genetics. 2010;42(6):504-7. Epub 2010/05/11. doi: 10.1038/ng.586 PMID: 20453838; PubMed Central PMCID: PMC3632836.
15. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature genetics. 2013;45(4):392-8, 8e1-2. Epub 2013/03/29. ng.2561 [pii] doi: 10.1038/ng.2561 PMID: 23535733; PubMed Central PMCID: PMC3771695.
16. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature genetics. 2013;45(4):371-84, 84e1-2. Epub 2013/03/29. ng.2566 [pii] doi: 10.1038/ng.2566 PMID: 23535731; PubMed Central PMCID: PMC3670748.
17. Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P, et al. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis. 2014;35(5):1012-9. Epub 2013/12/12. bgt404 [pii] doi: 10.1093/carcin/bgt404 PMID: 24325915; PubMed Central PMCID: PMC4004200.
18. Cai Q, Zhang B, Sung H, Low SK, Kweon SS, Lu W, et al. Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1. Nature genetics. 2014;46(8):886-90.
19. Long J, Cai Q, Sung H, Shi J, Zhang B, Choi JY, et al. Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet. 2012;8(2):e1002532.
20. Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Human molecular genetics. 2011;20(23):4693-706. Epub 2011/08/20. doi: 10.1093/hmg/ddr368 PMID: 21852249; PubMed Central PMCID: PMC3209823.
21. Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, Kohaar I, et al. NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations. Molecular cancer. 2010;9:113. Epub 2010/05/21. doi: 10.1186/1476-4598-9-113 PMID: 20482849; PubMed Central PMCID: PMC2887795.
22. Horne HN, Sherman ME, Garcia-Closas M, Pharoah PD, Blows FM, Yang XR, et al. Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression. Breast cancer research and treatment. 2014;143(1):181-7. doi: 10.1007/s10549-013-2771-z PMID: 24292867.
23. Sawyer E, Roylance R, Petridis C, Brook MN, Nowinski S, Papouli E, et al. Genetic predisposition to in situ and invasive lobular carcinoma of the breast. PLoS Genet. 2014;10(4):e1004285. doi: 10.1371/journal.pgen. 1004285 PMID: 24743323; PubMed Central PMCID: PMC3990493.
24. Chen Q, Shi R, Liu W, Jiang D. Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk. PloS one. 2013;8(8):e72487. doi: 10.1371/journal.pone.0072487 PMID: 23977306; PubMed Central PMCID: PMC3745461.
25. Wu S, Cai J, Wang H, Zhang H, Yang W. Association between 1p11-rs11249433 polymorphism and breast cancer susceptibility: evidence from 15 case-control studies. PloS one. 2013;8(8):e72526. doi: 10.1371/journal.pone.0072526 PMID: 23977314; PubMed Central PMCID: PMC3744559.
26. Jiang Y, Shen H, Liu X, Dai J, Jin G, Qin Z, et al. Genetic variants at 1p11.2 and breast cancer risk: a two-stage study in Chinese women. PloS one. 2011;6(6):e21563. doi: 10.1371/journal.pone.0021563 PMID: 21738711; PubMed Central PMCID: PMC3124527.
27. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5(6):e1000529. doi: 10.1371/journal.pgen. 1000529 PMID: 19543373; PubMed Central PMCID: PMC2689936.
28. International HapMap C, Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467(7311):52-8. doi: 10.1038/nature09298 PMID: 20811451; PubMed Central PMCID: PMC3173859.
29. Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061-73. doi: 10.1038/nature09534 PMID: 20981092; PubMed Central PMCID: PMC3042601.
30. Musumeci L, Arthur JW, Cheung FS, Hoque A, Lippman S, Reichardt JK. Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies. Hum Mutat. 2010;31(1):67-73. Epub 2009/10/31. doi: 10.1002/humu.21137 PMID: 19877174; PubMed Central PMCID: PMC2797835.
31. Sudmant PH, Kitzman JO, Antonacci F, Alkan C, Malig M, Tsalenko A, et al. Diversity of human copy number variation and multicopy genes. Science. 2010;330(6004):641-6. Epub 2010/10/30. 330/6004/641 [pii] doi: 10.1126/science.1197005 PMID: 21030649; PubMed Central PMCID: PMC3020103.
32. Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68-74. doi: 10.1038/nature15393 PMID: 26432245; PubMed Central PMCID: PMC4750478.
33. Luna A, Nicodemus KK. snp. plotter: an R-based SNP/haplotype association and linkage disequilibrium plotting package. Bioinformatics. 2007;23(6):774-6. doi: 10.1093/bioinformatics/btl657 PMID: 17234637.
34. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome research. 2002;12(6):996-1006. doi: 10.1101/gr.229102. Article published online before print in May 2002. PMID: 12045153; PubMed Central PMCID: PMC186604.
35. Corradin O, Scacheri PC. Enhancer variants: evaluating functions in common disease. Genome Med. 2014;6(10):85.
36. Bouras T, Pal B, Vaillant F, Harburg G, Asselin-Labat ML, Oakes SR, et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell stem cell. 2008;3(4):429-41. Epub 2008/10/23. doi: 10.1016/j.stem.2008.08.001 PMID: 18940734.
37. Hirose H, Ishii H, Mimori K, Ohta D, Ohkuma M, Tsujii H, et al. Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors. Oncology reports. 2010;23(1):35-43. PMID: 19956862.
38. Li L, Zhao F, Lu J, Li T, Yang H, Wu C, et al. Notch-1 signaling promotes the malignant features of human breast cancer through NF-kappaB activation. PloS one. 2014;9(4):e95912. doi: 10.1371/journal.pone.0095912 PMID: 24760075; PubMed Central PMCID: PMC3997497.
39. Suman S, Das TP, Damodaran C. Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells. British journal of cancer. 2013;109(10):2587-96. doi: 10.1038/bjc.2013.642 PMID: 24129237; PubMed Central PMCID: PMC3833225.
40. Wu F, Stutzman A, Mo YY. Notch signaling and its role in breast cancer. Frontiers in bioscience: a journal and virtual library. 2007;12:4370-83. PMID: 17485381.
41. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934-47. Epub 2013/10/15. S0092-8674 (13) 01227-0 [pii] doi: 10.1016/j.cell.2013.09.053 PMID: 24119843; PubMed Central PMCID: PMC3841062.
42. Parr C, Watkins G, Jiang WG. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med. 2004;14(5):779-86. Epub 2004/10/20. PMID: 15492845.
43. Long J, Zhang B, Signorello LB, Cai Q, Deming-Halverson S, Shrubsole MJ, et al. Evaluating genomewide association study-identified breast cancer risk variants in African-American women. PloS one. 2013;8(4):e58350. doi: 10.1371/journal.pone.0058350 PMID: 23593120; PubMed Central PMCID: PMC3620157.